Which hedge funds own ARTV? ARTIVA BIOTHERAPEUTICS INC, Q2 2026 13F holders
HealthcareBiotechnologyFollow
21 tracked hedge funds disclosed a position in ARTV (ARTIVA BIOTHERAPEUTICS INC) in their Q2 2026 13F filings, worth $293.5m in total. The largest holder by portfolio weight is 5AM Venture Management, LLC at 7.9% of its book. 13 opened a new position this quarter: KVP Capital Advisors, LP, Caligan Partners LP, Silverarc Capital Management, LLC, Spark Investment Management LLC. 1 exited: Millennium Management LLC.
21
Holders
Tracked managers whose filing for the quarter reports a long equity position in the security.
13
New this quarter
Holders whose previous filing (at most two quarters earlier) did not report the security.
1
Exited this quarter
Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
$59.1m
Inflow, new holders
Combined value of the positions the new holders reported for the quarter.
$794k
Outflow, exits
Combined value the exiting managers reported for the security in their previous filing.
$293m
Combined value
Sum of the holders' reported positions in the security.
1.7%
Share of managers holding
Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.